{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:28:56Z","timestamp":1790713736207,"version":"4.1.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Systemic Lupus Erythematosus (SLE) impacts the central nervous system (CNS), leading to severe neurological and psychiatric manifestations known as neuropsychiatric lupus (NPSLE). The complexity and heterogeneity of clinical presentations of NPSLE impede direct investigation of disease etiology in patients. The limitations of existing mouse models developed for NPSLE obstruct a comprehensive understanding of this disease. Hence, the identification of a robust mouse model of NPSLE is desirable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>C57BL\/6 mice transgenic for human MeCP2 (B6.<jats:italic>Mecp2<jats:sup>Tg1<\/jats:sup><\/jats:italic>) were phenotyped, including autoantibody profiling through antigen array, analysis of cellularity and activation of splenic immune cells through flow cytometry, and measurement of proteinuria. Behavioral tests were conducted to explore their neuropsychiatric functions. Immunofluorescence analyses were used to reveal altered neurogenesis and brain inflammation. Various signaling molecules implicated in lupus pathogenesis were examined using western blotting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>B6.<jats:italic>Mecp2<jats:sup>Tg1<\/jats:sup><\/jats:italic> exhibits elevated proteinuria and an overall increase in autoantibodies, particularly in female B6.<jats:italic>Mecp2<jats:sup>Tg1<\/jats:sup><\/jats:italic> mice. An increase in CD3<jats:sup>+<\/jats:sup>CD4<jats:sup>+<\/jats:sup> T cells in the transgenic mice was observed, along with activated germinal center cells and activated CD11b<jats:sup>+<\/jats:sup>F4\/80<jats:sup>+<\/jats:sup> macrophages. Moreover, the transgenic mice displayed reduced locomotor activity, heightened anxiety and depression, and impaired short-term memory. Immunofluorescence analysis revealed IgG deposition and immune cell infiltration in the kidneys and brains of transgenic mice, as well as altered neurogenesis, activated microglia, and compromised blood-brain barrier (BBB). Additionally, protein levels of various key signaling molecules were found to be differentially modulated upon MeCP2 overexpression, including GFAP, BDNF, Albumin, NCoR1, mTOR, and NLRP3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Collectively, this work demonstrates that B6.<jats:italic>Mecp2<jats:sup>Tg1<\/jats:sup><\/jats:italic> mice exhibit lupus-like phenotypes as well as robust CNS dysfunctions, suggesting its utility as a new animal model for NPSLE.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1370254","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T04:33:51Z","timestamp":1709872431000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune and neuropsychiatric phenotypes in a Mecp2 transgenic mouse model on C57BL\/6 background"],"prefix":"10.3389","volume":"15","author":[{"given":"Yaxi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatin","family":"Atrooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samina","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00138","article-title":"Definition of NPSLE: does the ACR nomenclature still hold","volume":"5","author":"Vivaldo","year":"2018","journal-title":"Front Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/bs.ai.2021.09.002","article-title":"Neuropsychiatric disorders: An immunological perspective","volume":"152","author":"Aw","year":"2021","journal-title":"Adv Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102911","article-title":"Cognitive dysfunction in SLE: an understudied clinical manifestation","volume":"102911","author":"Mizrachi","year":"2022","journal-title":"J Autoimmun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jneuroim.2008.11.009","article-title":"Depression is an early disease manifestation in lupus-prone MRL\/lpr mice","volume":"207","author":"Gao","year":"2009","journal-title":"J Neuroimmunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/207504","article-title":"The MRL\/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus","volume":"2011","author":"Gulinello","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-15-23","article-title":"Diagnosis and early detection of CNS-SLE in MRL\/lpr mice using peptide microarrays","volume":"15","author":"Williams","year":"2014","journal-title":"BMC Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370617","article-title":"Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus","volume":"37","author":"Vogelweid","year":"1994","journal-title":"Arthritis Rheumatism: Off J Am Coll Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1006\/brbi.1996.0023","article-title":"Anxiety behavior, exploratory behavior, and activity in NZB\u00d7 NZW F1 hybrid mice: role of genotype and autoimmune disease progression","volume":"10","author":"Schrott","year":"1996","journal-title":"Brain Behav Immun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbi.2018.03.009","article-title":"FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus","volume":"70","author":"Shi","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2018.08.005","article-title":"Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus","volume":"96","author":"Mike","year":"2019","journal-title":"J Autoimmun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90610-O","article-title":"Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA","volume":"69","author":"Lewis","year":"1992","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/20.19.5085","article-title":"Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA","volume":"20","author":"Meehan","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.9.1377","article-title":"MECP2 mutations account for most cases of typical forms of Rett syndrome","volume":"9","author":"Bienvenu","year":"2000","journal-title":"Hum Mol Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.5.611","article-title":"MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features","volume":"56","author":"Auranen","year":"2001","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/mrdd.10026","article-title":"Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype","volume":"8","author":"Hoffbuhr","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.6.2065","article-title":"FVB\/N: an inbred mouse strain preferable for transgenic analyses","volume":"88","author":"Taketo","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum Mol Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"163ra158","DOI":"10.1126\/scitranslmed.3004430","article-title":"Overexpression of methyl-CpG binding protein 2 impairs TH1 responses","volume":"4","author":"Yang","year":"2012","journal-title":"Sci Trans Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001727","article-title":"Common variants within MECP2 confer risk of systemic lupus erythematosus","volume":"3","author":"Sawalha","year":"2008","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2698","article-title":"Replication of recently identified systemic lupus erythematosus genetic associations: a case\u2013control study","volume":"11","author":"Suarez-Gestal","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.24360","article-title":"Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus","volume":"60","author":"Webb","year":"2009","journal-title":"Arthritis Rheumatism: Off J Am Coll Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313496340","article-title":"Association of MeCP2 (rs2075596, rs2239464) genetic polymorphisms with systemic lupus erythematosus: a meta-analysis","volume":"22","author":"Liu","year":"2013","journal-title":"Lupus"},{"key":"B25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/biom10030494","article-title":"The role of MECP2 and CCR5 polymorphisms on the development and course of systemic lupus erythematosus","volume":"10","author":"Rzeszotarska","year":"2020","journal-title":"Biomolecules"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.12.012","article-title":"Functional characterization of the MECP2\/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse","volume":"41","author":"Koelsch","year":"2013","journal-title":"J Autoimmun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(90)90051-Q","article-title":"Anti-histone antibodies in the serum of autoimmune MRL and NZBNZW1 F1 mice","volume":"54","author":"Brick","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.07.020","article-title":"Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice","volume":"229","author":"Gao","year":"2010","journal-title":"J Neuroimmunol"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-7231-9_20","article-title":"Protein arrays II: antigen arrays","volume-title":"Functional Genomics","author":"Yuan","year":"2017"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190056","article-title":"Brain amyloid-\u03b2 deposition and blood biomarkers in patients with clinically diagnosed Alzheimer\u2019s disease","volume":"69","author":"Li","year":"2019","journal-title":"J Alzheimer's Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1800114","DOI":"10.1002\/prca.201800114","article-title":"Discovery of IgG4 anti-gliadin autoantibody as a potential biomarker of psoriasis using an autoantigen array","volume":"14","author":"Qiu","year":"2020","journal-title":"PROTEOMICS\u2013Clin Appl"},{"key":"B32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"psychol Bull"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3791\/52434-v","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","volume":"96","author":"Seibenhener","year":"2015","journal-title":"JoVE (J Visualized Experiments)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3791\/1088","article-title":"Elevated plus maze for mice","volume":"22","author":"Komada","year":"2008","journal-title":"JoVE (J Visualized Experiments)"},{"key":"B35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-60761-303-9_11","article-title":"The mouse light\u2013dark box test","volume-title":"Mood and Anxiety Related Phenotypes in Mice","author":"Hascoet","year":"2009"},{"key":"B36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3791\/3769-v","article-title":"The tail suspension test","volume":"59","author":"Can","year":"2012","journal-title":"JoVE (J Visualized Experiments)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat Protoc"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2006.03.023","article-title":"Pten regulates neuronal arborization and social interaction in mice","volume":"50","author":"Kwon","year":"2006","journal-title":"Neuron"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124203","article-title":"Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus","volume":"4","author":"Stock","year":"2019","journal-title":"JCI Insight"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16907-0","article-title":"MeCP2 regulates gene expression through recognition of H3K27me3","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1749-6632.1997.tb48382.x","article-title":"Animal models for nervous system disease in systemic lupus erythematosus","volume":"823","author":"Brey","year":"1997","journal-title":"Ann New York Acad Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33184","article-title":"The MECP2 duplication syndrome","volume":"152","author":"Ramocki","year":"2010","journal-title":"Am J Med Genet Part A"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36380","article-title":"MECP2 duplication: possible cause of severe phenotype in females","volume":"164","author":"Scott Schwoerer","year":"2014","journal-title":"Am J Med Genet Part A"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-06916-3","article-title":"Altered visual cortical processing in a mouse model of MECP2 duplication syndrome","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.10.001","article-title":"Gender and autoimmunity","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.20","article-title":"Plasma cells as an innovative target in autoimmune disease with renal manifestations","volume":"12","author":"Hiepe","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12321","article-title":"Germinal centers and autoantibodies","volume":"98","author":"Young","year":"2020","journal-title":"Immunol Cell Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03020","article-title":"Predominant role of immunoglobulin G in the pathogenesis of splenomegaly in murine lupus","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.4049\/jimmunol.1003010","article-title":"A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis","volume":"186","author":"Bethunaickan","year":"2011","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature16159","article-title":"Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides","volume":"528","author":"Sztainberg","year":"2015","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2822","article-title":"New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory","volume":"11","author":"Deng","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"science"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nn1969","article-title":"Adult hippocampal neurogenesis in depression","volume":"10","author":"Sahay","year":"2007","journal-title":"Nat Neurosci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200620230321","article-title":"Crosstalk between inflammation and the BBB in stroke","volume":"18","author":"Huang","year":"2020","journal-title":"Curr Neuropharmacol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nature22821","article-title":"Microglia-dependent synapse loss in type I interferon-mediated lupus","volume":"546","author":"Bialas","year":"2017","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180776","article-title":"Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors","volume":"215","author":"Nestor","year":"2018","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.12.008","article-title":"Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice","volume":"67","author":"Crupi","year":"2010","journal-title":"Biol Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00080","article-title":"The choroid plexus\u2014a multi-role player during infectious diseases of the CNS","volume":"9","author":"Schwerk","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/art.42252","article-title":"Choroid plexus\u2013infiltrating T cells as drivers of murine neuropsychiatric lupus","volume":"74","author":"Moore","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2013-0193","article-title":"MeCP2 phosphorylation in the brain: from transcription to behavior","volume":"394","author":"Damen","year":"2013","journal-title":"Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2821-13.2014","article-title":"MeCP2 phosphorylation limits psychostimulant-induced behavioral and neuronal plasticity","volume":"34","author":"Deng","year":"2014","journal-title":"J Neurosci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2006.09.037","article-title":"Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation","volume":"52","author":"Zhou","year":"2006","journal-title":"Neuron"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0901518106","article-title":"The yin and yang of MeCP2 phosphorylation","volume":"106","author":"Chao","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0811648106","article-title":"Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function","volume":"106","author":"Tao","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu251","article-title":"Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus","volume":"53","author":"Tamashiro","year":"2014","journal-title":"Rheumatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/096120330000900704","article-title":"Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement","volume":"9","author":"Trysberg","year":"2000","journal-title":"Lupus"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00290244","article-title":"Diagnosis and pathogenesis of CNS lupus","volume":"11","author":"Van Dam","year":"1991","journal-title":"Rheumatol Int"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/art.11279","article-title":"Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement","volume":"48","author":"Trysberg","year":"2003","journal-title":"Arthritis Rheumatism"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription","volume":"19","author":"Jones","year":"1998","journal-title":"Nat Genet"},{"key":"B72","first-page":"173","article-title":"mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus","volume":"9","author":"Fernandez","year":"2010","journal-title":"Discovery Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu429","article-title":"Meta-analysis of GWAS on two Chinese populations followed by replication identifies novel genetic variants on the X chromosome associated with systemic lupus erythematosus","volume":"24","author":"Zhang","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: a promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1370254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T04:33:58Z","timestamp":1709872438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1370254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":74,"alternative-id":["10.3389\/fimmu.2024.1370254"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1370254","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"article-number":"1370254"}}